| Literature DB >> 23209512 |
Hartmut Schedel1, Keizo Kan, Yoshihiro Ueda, Kenji Mishiro, Keisuke Yoshida, Takumi Furuta, Takeo Kawabata.
Abstract
In this work we developed C(2)-symmetric chiral nucleophilic catalysts which possess a pyrrolidinopyridine framework as a catalytic site. Some of these organocatalysts effectively promoted asymmetric desymmetrization of meso-diols via enantioselective acylation.Entities:
Keywords: acylation; desymmetrization; hydrogen bond; meso-diol; nucleophilic catalyst; organocatalysis
Year: 2012 PMID: 23209512 PMCID: PMC3511012 DOI: 10.3762/bjoc.8.203
Source DB: PubMed Journal: Beilstein J Org Chem ISSN: 1860-5397 Impact factor: 2.883
Figure 1Chiral PPY catalysts.
Scheme 1Asymmetric desymmetrization of 5 with catalyst 3.
Scheme 2Preparation of a small library of chiral C2-symmetric PPY catalysts (reference, see [12]).
Effects of the catalysts’ side chains on the asymmetric desymmetrization of meso-1,2-cyclohexanediol (5).a
| Entry | Catalystb | ee of | |
| 1 | 85:15:0 | 73 | |
| 2 | 70:18:12 | 54 | |
| 3 | 74:16:10 | 72 | |
| 4 | 72:19:9 | 71 | |
| 5 | 75:23:3 | 87 | |
| 6 | 70:25:5 | 74 | |
| 7 | 77:14:9 | 83 | |
| 8 | 76:18:6 | 54 | |
| 9 | 75:20:5 | 81 | |
aReactions were run at a substrate concentration of 0.2 M.
bStructures of catalysts:
.
cYields determined by 1H NMR with dibenzyl ether as an internal standard. dDetermined by GC analysis with a chiral stationary phase, beta-DEX 225. e(1R,2S)-Isomer was obtained in each case.
Effects of solvents and temperature on the asymmetric desymmetrization of 5.a
| Entry | Catalyst | Solvent | Temp. (°C) | ee of | |
| 1 | CCl4 | 20 °C | 75:20:5 | 93 | |
| 2 | toluene | 20 °C | 75:19:6 | 91 | |
| 3 | CHCl3 | 20 °C | 77:14:9 | 83 | |
| 4 | THF | 20 °C | 57:28:15 | 51 | |
| 5 | CH3CN | 20 °C | 69:23:8 | 34 | |
| 6 | CHCl3 | 20 °C | 75:20:5 | 81 | |
| 7e | CHCl3 | 85:6:9 | 87 | ||
| 8 | CHCl3 | 20 °C | 75:23:2 | 87 | |
| 9e | CHCl3 | 92:5:3 | 88 | ||
aReactions were run at a substrate concentration of 0.2 M. bYields determined by 1H NMR with dibenzyl ether as an internal standard. cDetermined by GC analysis with a chiral stationary phase, beta-DEX 225. d(1R,2S)-Isomer was obtained in each case. eRun for 24 h.
Figure 2A hypothetical model for the transition-state assembly of the asymmetric acylation of 5 promoted by catalyst 11. Front view a) and side view b) of the calculated structure of acylpyridinium ion A. Front view c) and side view d) of the possible modes for the substrate approach to A.
Figure 3An alternative model for the transition state assembly of the asymmetric acylation of 5 promoted by catalyst 11. a) A possible mode of the substrate approach to acylpyridinium ion A, and b) the calculated structure of A.
Optimization of the asymmetric desymmetrization of 5 with catalyst 11.a
| Entry | Mol % of | Equiv of (iPrCO)2O | ee of | |
| 1 | 5 | 1.3 | 75:23:2 | 87 |
| 2e | 0.5 | 1.3 | 76:20:3 | 90 |
| 3 | 0.05 | 1.3 | 66:10:24 | 74 |
| 4 | 5 | 1.0 | 84: 7:4 | 81 |
| 5e,f | 5 | 1.6 | 59:41:0 | 98 |
aReactions were run at a substrate concentration of 0.2 M. bYields determined by 1H NMR with dibenzyl ether as an internal standard. cDetermined by GC analysis with a chiral stationary phase, beta-DEX 225. d(1R,2S)-Isomer was obtained in each case. eData quoted from reference [20]. f1.7 Equiv of collidine were used.
Scheme 3Amplification of enantiomeric purity of the major enantiomer produced at the step of asymmetric desymmetrization of the meso-substrate by the following kinetic resolution with the same catalyst.
Scheme 4Acylative kinetic resolution of racemic-6 with catalyst 12b.
Effects of side chain linkage and C2-symmetric structure of catalysts on the asymmetric desymmetrization of 5.a
| Entry | Catalystb | ee of | |
| 1 | 75:23:3 | 87 | |
| 2 | 79:15:6 | 13 | |
| 3 | 65:24:11 | 13 | |
| 4 | 70:26:4 | 76 | |
| 5 | 61:34:5 | 41 | |
| 6 | 70:25:5 | 74 | |
aReactions were run at a substrate concentration of 0.2 M.
bStructures of catalysts
.
cYields determined by 1H NMR with dibenzyl ether as an internal standard. dDetermined by GC analysis with a chiral stationary phase, beta-DEX 225. e(1R,2S)-Isomer was obtained in each case.
The asymmetric desymmetrization of meso-1,3-cyclohexanediol (19) with C2-symmetric chiral PPY catalysts.a
| Entry | Catalyst | Temp. (°C) | Time (h) | ee of | |
| 1 | 0 | 12 | 66:15:17 | 48 | |
| 2 | –40 | 48 | 26: 2:72 | 50 | |
| 3 | 20 | 4 | 69:24:7 | 31 | |
| 4 | –40 | 48 | 44:10:44 | 25 | |
| 5 | 20 | 4 | 48:43:9 | 27 | |
| 6 | 20 | 4 | 49:30:21 | 20 | |
| 7 | 20 | 4 | 62:33:6 | 19 | |
aReactions were run at a substrate concentration of 0.2 M. bYields determined by 1H NMR with dibenzyl ether as an internal standard. cDetermined by GC analysis with a chiral stationary phase, beta-DEX 225. dThe absolute configuration of 20 was not determined.
The asymmetric desymmetrization of meso-2,3-butanediol (22a), meso-hydrobenzoin (22b) and meso-1,2-cyclopentanediol (22c).a
| Entry | Substrate | Catalystb | Temp. (°C) | Time (h) | ee of | |
| 1 | 20 | 4 | 78:11:11 | 53d,e | ||
| 2 | 20 | 4 | 77:16:7 | 62d,e | ||
| 3 | 20 | 4 | 78:13:9 | 66d,e | ||
| 4f | −60 | 24 | 72:7:21 | 87d,e | ||
| 5 | 20 | 4 | 72:6:22 | 61d,e | ||
| 6 | 20 | 24 | 73:18:9 | 57d,e | ||
| 7 | −40 | 24 | 82:4:14 | 85d,e | ||
| 8f | −65 | 24 | 61:<1:39 | 92d,e | ||
| 9 | 20 | 4 | 64:25:11 | 40g,h | ||
| 10 | 20 | 4 | 63:22:15 | 23g,h | ||
| 11 | 20 | 4 | 54:25:21 | 19g,h | ||
| 12 | −20 | 6 | 85:12:3 | ~0i | ||
| 13 | −20 | 4 | 73:27:0 | ~0i | ||
| 14j | −20 | 4 | 67:33:0 | ~0i | ||
aReactions were run at a substrate concentration of 0.2 M.
bStructure of catalyst 25:
cYields determined by 1H NMR with dibenzyl ether as an internal standard. dEe was determined by GC analysis with a chiral stationary phase, beta-DEX 225. e(2R,3S)-Isomer was obtained. fData quoted from reference [20]. gEe was determined by HPLC analysis with a chiral stationary phase, Chiralcel OJ (iPrOH:hexane = 5:95, flow 0.5 mL min−1, tR = 35, 51 min). hThe absolute configuration was not determined. iEe of the corresponding benzoate, which was determined by HPLC analysis with a chiral stationary phase, Chiralcel AS (iPrOH/hexane 1:99, flow 0.2 mL min−1, tR = 43, 49 min). jRun in toluene.